V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330005621 | 330002678 | 1.16 | null | null | 2017-03-10 | 2017-03-11 | VIDE | 99 | null | 330024258 | CARBOPLATIN + PEMETREXED |
| 330005622 | 330002678 | null | 59.7 | Curative (C) | 2013-04-18 | 2013-05-02 | UKALL14- Ph 1 Induction | N | N | 330024258 | AZACITIDINE |
| 330005623 | 330002678 | 1.5 | null | null | null | 2014-07-03 | METHOTREXATE | null | null | 330024258 | IPILIMUMAB |
| 330005624 | 330002678 | 0 | 22.8 | Curative (C) | 2013-12-14 | 2013-12-16 | UKALL14- Ph 1 Induction | N | N | 330024258 | CVP |
| 330005625 | 330002678 | 1.56 | 49 | null | 2013-12-11 | 2013-12-16 | ECarboX | N | N | 330024258 | ACE (GERM CELL) |
| 330005626 | 330002678 | 1.53 | 56.9 | Curative (C) | 2017-05-11 | 2017-05-19 | EMA/CO | 02 | N | 330024258 | VIDE |
| 330005627 | 330002679 | null | 111 | Palliative (P) | 2015-10-04 | 2015-10-25 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 330024278 | CISPLATIN + FLUOROURACIL + RT |
| 330005628 | 330002680 | 1.67 | 79.8 | Palliative (P) | 2013-10-16 | 2013-10-16 | VIDE | N | N | 330024279 | CARBOPLATIN + RT |
| 330005629 | 330002680 | 1.8 | 68.9 | Palliative (P) | 2017-12-26 | 2018-01-01 | AML16 Low Dose Cytarabine | 02 | null | 330024279 | CARBOPLATIN + RT |
| 330005630 | 330002680 | 1.68 | 70 | null | 2013-01-31 | 2013-01-31 | Methotrexate Intrathecal (any age) | N | N | 330024279 | CHLORAMBUCIL |
| 330005631 | 330002680 | 1.67 | 60.5 | Palliative (P) | 2016-03-19 | 2016-04-01 | TCF | 2 | N | 330024279 | CARBOPLATIN + CETUXIMAB + FU |
| 330005632 | 330002681 | 0 | 74.1 | Palliative (P) | 2013-01-10 | 2013-01-10 | PAC-E | 02 | N | 330024289 | FLAG + IDARUBICIN |
| 330005633 | 330002681 | 1.8 | 65.2 | Adjuvant (A) | 2017-02-15 | 2017-02-15 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 330024289 | BEP |
| 330005634 | 330002681 | 1.61 | 123.5 | Curative (C) | 2017-12-26 | 2017-12-29 | CVD (Neuroendocrine) | N | N | 330024289 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 330005635 | 330002682 | 1.73 | 75 | Curative (C) | null | 2013-09-16 | Capecitabine | null | null | 330024298 | TCF |
| 330005636 | 330002683 | 1.54 | 37.2 | Curative (C) | 2013-11-18 | 2013-11-18 | Carboplatin + Vinorelbine IV &PO D8 | 2 | N | 330024306 | CARBOPLATIN + VINCRISTINE |
| 330005637 | 330002684 | null | 67.4 | Curative (C) | 2014-11-23 | 2014-11-24 | IVA | 02 | N | 330024307 | DOXORUBICIN + IFOSFAMIDE |
| 330005638 | 330002685 | 0 | 56 | null | 2014-05-20 | 2014-05-21 | Capecitabine | 02 | N | 330024313 | VIDE |
| 330005639 | 330002685 | null | 49 | Curative (C) | 2013-05-18 | 2013-05-23 | Ifosfamide | N | N | 330024313 | ECX |
| 330005640 | 330002685 | 2 | 81.3 | Disease modification (D) | 2014-06-15 | 2014-06-16 | Capecitabine | N | N | 330024313 | CISPLATIN + DOXORUBICIN + ETOPOSIDE |
| 330005641 | 330002686 | 1.85 | 72 | null | 2013-09-28 | 2013-09-29 | Vemurafenib | 02 | null | 330024325 | CISPLATIN + DOCETAXEL |
| 330005642 | 330007470 | 0 | 81.2 | Palliative (P) | 2013-07-16 | 2013-07-16 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 330024326 | CISPLATIN + FLUOROURACIL + RT |
| 330005643 | 330002687 | 1.64 | 79 | Curative (C) | 2016-02-15 | 2016-02-16 | AML17 TRIAL | 2 | N | 330024346 | FCR |
| 330005644 | 330002687 | null | 66.4 | Palliative (P) | 2016-12-21 | 2016-12-21 | Bortezomib +/- Dexamethasone | 02 | N | 330024346 | CAPECITABINE + IRINOTECAN |
| 330005645 | 330002687 | null | null | Not known (9) | 2016-05-22 | 2016-05-22 | Doxorubicin + Ifosfamide | N | null | 330024346 | DECITABINE |
| 330005646 | 330002688 | 1.68 | 10.6 | Curative (C) | 2015-03-25 | 2015-04-12 | Midostaurin | N | N | 330024355 | CHOP R |
| 330005649 | 330010061 | 1.69 | 94.2 | Curative (C) | 2013-06-12 | 2013-06-12 | Bortezomib + Cyclophos + Dex | N | N | 330024370 | CAPE + CARBOPLATIN + CETUXIMAB |
| 330005653 | 330002690 | 1.49 | 60 | Curative (C) | 2016-04-13 | 2016-04-21 | EDP + MITOTANE | N | N | 330024385 | ECX |
| 330005654 | 330002690 | null | 53.9 | Curative (C) | null | 2013-09-28 | ECX | null | null | 330024385 | CISPLATIN + VINORELBINE |
| 330005655 | 330002690 | null | 78.35 | null | 2016-06-23 | 2016-07-13 | FCR | Y | null | 330024385 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 330005656 | 330002691 | 1.72 | 91.5 | Palliative (P) | null | 2014-06-30 | CARBOPLATIN + RT | null | null | 330024392 | CYTARABINE |
| 330005657 | 330002691 | 1.48 | 0 | Disease modification (D) | 2015-01-10 | 2015-01-23 | GDP | 02 | N | 330024392 | SUNITINIB |
| 330005658 | 330002691 | null | null | Not known (9) | 2015-10-20 | 2015-10-27 | Ipilimumab | N | N | 330024392 | CHOP R |
| 330005659 | 330002691 | 1.65 | null | Palliative (P) | 2019-01-26 | 2019-02-02 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 330024392 | CISPLATIN + FLUOROURACIL + RT |
| 330005660 | 330002691 | 1.82 | 11.2 | Curative (C) | 2016-10-18 | 2016-10-18 | BEP 3 day | Y | N | 330024392 | CYTARABINE |
| 330005661 | 330002692 | 1.71 | null | Palliative (P) | 2015-10-31 | 2015-11-09 | Vincristine (weekly) | 02 | null | 330024411 | UKALL2014 |
| 330005662 | 330002693 | 0 | 85.2 | Curative (C) | 2015-03-01 | 2015-03-06 | ALL UKALL2011 Maintenance A4 | N | N | 330024412 | FLUOROURACIL |
| 330005663 | 330002694 | null | 73.6 | Curative (C) | 2015-04-02 | 2015-04-10 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | N | N | 330024413 | METHOTREXATE |
| 330005671 | 330002696 | null | null | Palliative (P) | 2016-07-16 | 2016-07-19 | Cisplatin + Vinorelbine (IV) | 99 | N | 330024436 | GEMCITABINE |
| 330005672 | 330002697 | 1.68 | 49.4 | Curative (C) | 2014-12-22 | 2015-01-06 | Cisplatin + Vinorelbine (IV) | N | N | 330024440 | CISPLATIN + VINORELBINE |
| 330005673 | 330007476 | null | null | Curative (C) | 2013-08-02 | 2013-08-06 | CNS LGG 2004 03 vinc weekly+ carbo | Y | null | 330024442 | CAV |
| 330005674 | 330007476 | 1.65 | null | Curative (C) | null | 2013-08-31 | Hydroxycarbamide | null | null | 330024442 | AZACITIDINE |
| 330005675 | 330007476 | 1.78 | 89.3 | Curative (C) | null | 2014-12-14 | Azacitidine | Y | N | 330024442 | CETUXIMAB + CISPLATIN + FU |
| 330005676 | 330007476 | 156.4 | 0 | Palliative (P) | 2014-11-16 | 2014-11-21 | AML17 TRIAL | N | N | 330024442 | FCR |
| 330005677 | 330007476 | 1.73 | 91.8 | Palliative (P) | 2012-01-24 | 2013-05-11 | Doxorubicin + Ifosfamide | N | N | 330024442 | DOCETAXEL |
| 330005679 | 330002698 | 1.74 | 72.4 | Palliative (P) | null | 2017-08-14 | CNS Low Grade Glioma Vinblastine | N | N | 330024458 | ECX |
| 330005680 | 330002699 | 1.64 | 53 | Palliative (P) | 2017-10-24 | 2017-10-24 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 330024462 | BEVACIZUMAB |
| 330005681 | 330002700 | null | null | Curative (C) | 2014-05-15 | 2014-05-17 | FLAG + Idarubicin | Y | N | 330024464 | PEI |
| 330005682 | 330002700 | 1.74 | 93.5 | Curative (C) | 2016-01-07 | 2016-01-09 | CHOP R - 21 days | 02 | N | 330024464 | CYTARABINE |
| 330005683 | 330002700 | 1.79 | 60.9 | Palliative (P) | 2013-12-03 | 2013-12-03 | CETUXIMAB + CISPLATIN + FU | 2 | N | 330024464 | PEI |